<DOC>
	<DOC>NCT01785095</DOC>
	<brief_summary>The purpose of the study is to evaluate immunogenic potential of FSH-IBSA in healthy volunteers undergoing controlled ovarian hyperstimulation (COH) in an oocyte donation program.</brief_summary>
	<brief_title>Immunogenicity of Repeated Follicle Stimulating Hormone (FSH) Stimulation Cycles</brief_title>
	<detailed_description />
	<mesh_term>Hormones</mesh_term>
	<mesh_term>Follicle Stimulating Hormone</mesh_term>
	<criteria>Healthy female volunteers undergoing controlled ovarian hyperstimulation for oocyte donation with the following characteristics: Able and willing to sign the Subject Consent Form and adhere to the study visit schedule; &gt;=18 and &lt;35 years old; Regular menstrual cycle (26 35 days); BMI between 18 and 30 kg/m2; First gonadotrophin treatment (i.e. naïve Subjects with regard to exposure to human derived or recombinant gonadotrophins); basal FSH &lt;10 IU/L and E2 &lt;80 pg/ml (~290 pmol/l); Normal TSH levels; Willing to perform at least two consecutive oocyte retrieval cycles (with a wash out period of two months). Age &lt;18 and &gt;=35 years; PCOS; Endometriosis; Subjects with evidences of autoimmune or rheumatic diseases; Hypersensitivity to the active substance or to any of the excipients (lactose); Abnormal bleeding of undetermined origin; Subject found to be positive to antiTSH antibodies (i.e. suffering from thyroidal diseases); Uncontrolled adrenal dysfunction; Neoplasia; Severe impairment of renal and/or hepatic function; Use of concomitant medications that might interfere with study evaluations (e.g. immunosuppressant, nonstudy hormonal medications, therapeutics proteins like insulin, growth hormone…).</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>